W. Alderton

8.3k total citations · 2 hit papers
32 papers, 6.2k citations indexed

About

W. Alderton is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, W. Alderton has authored 32 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cell Biology and 10 papers in Physiology. Recurrent topics in W. Alderton's work include Nitric Oxide and Endothelin Effects (8 papers), Zebrafish Biomedical Research Applications (8 papers) and Receptor Mechanisms and Signaling (5 papers). W. Alderton is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Zebrafish Biomedical Research Applications (8 papers) and Receptor Mechanisms and Signaling (5 papers). W. Alderton collaborates with scholars based in United Kingdom, Ireland and Australia. W. Alderton's co-authors include Richard G. Knowles, Chris E. Cooper, Stéphane Berghmans, Alan G. Roach, Angeleen Fleming, Teresa P. Barros, Frances M. Richards, Zoe Golder, Paul Butler and Paul Goldsmith and has published in prestigious journals such as Scientific Reports, Biochemical Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

W. Alderton

30 papers receiving 6.1k citations

Hit Papers

Nitric oxide synthases: structure, function and inhibition 2001 2026 2009 2017 2001 2001 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nitric oxide synthases: structure, function and inhibition
    2001 2.9k citations W. Alderton, Chris E. Cooper et al. Biochemical Journal profile →
  2. Nitric oxide synthases: structure, function and inhibition
    2001 2.2k citations W. Alderton, Chris E. Cooper et al. Biochemical Journal profile →

Peers

W. Alderton
David Jourd’heuil United States
Douglas T. Hess United States
Juan José Poderoso Argentina
Husam M. Abu‐Soud United States
Douglas D. Thomas United States
Peter Klatt Spain
Wolfgang F. Graier Austria
Alberto Boveris Argentina
John P. Crow United States
Mark A. Yorek United States
David Jourd’heuil United States
W. Alderton
Citations per year, relative to W. Alderton W. Alderton (= 1×) peers David Jourd’heuil

Countries citing papers authored by W. Alderton

Since Specialization
Citations

This map shows the geographic impact of W. Alderton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Alderton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Alderton more than expected).

Fields of papers citing papers by W. Alderton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Alderton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Alderton. The network helps show where W. Alderton may publish in the future.

Co-authorship network of co-authors of W. Alderton

This figure shows the co-authorship network connecting the top 25 collaborators of W. Alderton. A scholar is included among the top collaborators of W. Alderton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Alderton. W. Alderton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valbuena, Gabriel N., Sophia Apostolidou, W. Alderton, et al.. (2019). The 14q32 maternally imprinted locus is a major source of longitudinally stable circulating microRNAs as measured by small RNA sequencing. Scientific Reports. 9(1). 15787–15787. 7 indexed citations
2.
3.
Apostolidou, Sophia, Richard Gunu, Andy Ryan, et al.. (2015). Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. British Journal of Cancer. 113(2). 268–274. 92 indexed citations
4.
5.
Young, Robert J., W. Alderton, Paul Beswick, et al.. (2011). Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(10). 3037–3040. 2 indexed citations
6.
Alderton, W., Stéphane Berghmans, Paul Butler, et al.. (2010). Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae. Xenobiotica. 40(8). 547–557. 94 indexed citations
7.
Buckley, Clare E., Alan G. Roach, Paul Goldsmith, et al.. (2010). Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects. Neuropharmacology. 59(3). 149–159. 64 indexed citations
8.
Buckley, Clare E., et al.. (2010). Temporal dynamics of myelination in the zebrafish spinal cord. Glia. 58(7). 802–812. 54 indexed citations
9.
Alderton, W., Eric Karran, & Simon E. Ward. (2009). Current and future perspectives in psychiatric drug discovery. Drug News & Perspectives. 22(6). 360–360. 6 indexed citations
10.
Barros, Teresa P., et al.. (2008). Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. British Journal of Pharmacology. 154(7). 1400–1413. 213 indexed citations
11.
Berghmans, Stéphane, Paul Butler, Paul Goldsmith, et al.. (2008). Zebrafish based assays for the assessment of cardiac, visual and gut function — potential safety screens for early drug discovery. Journal of Pharmacological and Toxicological Methods. 58(1). 59–68. 150 indexed citations
12.
Alderton, W., John Dawson, Edward P. Garvey, et al.. (2005). GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology. 145(3). 301–312. 77 indexed citations
13.
Alderton, W., Chris E. Cooper, & Richard G. Knowles. (2001). Nitric oxide synthases: structure, function and inhibition. Biochemical Journal. 357(3). 593–593. 2906 indexed citations breakdown →
14.
Gutiérrez, Aldo, et al.. (2001). Kinetics of CO binding to the haem domain of murine inducible nitric oxide synthase: differential effects of haem domain ligands. Biochemical Journal. 358(1). 201–201. 31 indexed citations
15.
Gutiérrez, Aldo, et al.. (2001). Kinetics of CO binding to the haem domain of murine inducible nitric oxide synthase: differential effects of haem domain ligands. Biochemical Journal. 358(1). 201–208. 17 indexed citations
16.
Alderton, W., Chris E. Cooper, & Richard G. Knowles. (2001). Nitric oxide synthases: structure, function and inhibition. Biochemical Journal. 357(3). 593–615. 2217 indexed citations breakdown →
17.
Alderton, W., Angela Boyhan, & Peter N. Lowe. (1998). Nitroarginine and tetrahydrobiopterin binding to the haem domain of neuronal nitric oxide synthase using a scintillation proximity assay. Biochemical Journal. 332(1). 195–201. 21 indexed citations
18.
Alderton, W., D R Thatcher, & Christopher R. Lowe. (1995). Affinity Labeling of Recombinant Ricin A Chain with Procion Blue MX‐R. European Journal of Biochemistry. 233(3). 880–885. 3 indexed citations
19.
Alderton, W., Christopher R. Lowe, & D R Thatcher. (1994). Purification of recombinant ricin A chain with immobilised triazine dyes. Journal of Chromatography A. 677(2). 289–299. 10 indexed citations
20.
Lowe, Christopher R., et al.. (1992). Designer dyes: ‘biomimetic’ ligands for the purification of pharmaceutical proteins by affinity chromatography. Trends in biotechnology. 10(12). 442–448. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Jourd’heuil Breakdown of academic impact, for papers by Douglas T. Hess Breakdown of academic impact, for papers by Juan José Poderoso Breakdown of academic impact, for papers by Husam M. Abu‐Soud Breakdown of academic impact, for papers by Douglas D. Thomas Breakdown of academic impact, for papers by Peter Klatt Breakdown of academic impact, for papers by Wolfgang F. Graier Breakdown of academic impact, for papers by Alberto Boveris Breakdown of academic impact, for papers by John P. Crow Breakdown of academic impact, for papers by Mark A. Yorek
Rankless by CCL
2026